Green Hygienics Holdings Inc (GRYN) 0.8500 $GRYN
Green Hygienics Holdings, Inc. - Management Discussion
Marketwired - Mon Jul 27, 8:57AM CDT
Green Hygienics Holdings, Inc. (OTCQB: GRYN)
Green Hygienics Appoints New Chief Financial Officer
Marketwired - Tue Jun 30, 9:18AM CDT
(OTCQB: GRYN) Green Hygienics Holdings, Inc., a large scale, turn-key commercial indoor cultivation company is pleased to announce the appointment of David Alexander, CA as its new CFO, effective immediately. David graduated with BComm in Finance from the University of British Columbia. He has managed the rapid growth of several early stage and startup companies. As CFO of Arakis Energy Corporation, an international oil and gas development company, he managed its growth from startup to over a billion dollars in assets, and listed it on Nasdaq. Arakis was subsequently sold to Talisman Energy Inc. He was also CFO of Nortran Pharmaceuticals, Inc., a University of British Colombia based pharmaceutical Research and Development Company engaged in the development and commercialization of cardiovascular therapies. While at Nortran, David helped secure initial and ongoing research financing. Nortran subsequently, became Cardiome Pharma Corp., a successful Vancouver BC based pharmaceutical company.
CRME: 8.53 (+0.40), TLM: 7.99 (unch)
Green Hygienics Holdings, Inc. - Management Discussion
Marketwired - Mon Jul 27, 8:57AM CDT
Green Hygienics Holdings, Inc. (OTCQB: GRYN)
Green Hygienics Appoints New Chief Financial Officer
Marketwired - Tue Jun 30, 9:18AM CDT
(OTCQB: GRYN) Green Hygienics Holdings, Inc., a large scale, turn-key commercial indoor cultivation company is pleased to announce the appointment of David Alexander, CA as its new CFO, effective immediately. David graduated with BComm in Finance from the University of British Columbia. He has managed the rapid growth of several early stage and startup companies. As CFO of Arakis Energy Corporation, an international oil and gas development company, he managed its growth from startup to over a billion dollars in assets, and listed it on Nasdaq. Arakis was subsequently sold to Talisman Energy Inc. He was also CFO of Nortran Pharmaceuticals, Inc., a University of British Colombia based pharmaceutical Research and Development Company engaged in the development and commercialization of cardiovascular therapies. While at Nortran, David helped secure initial and ongoing research financing. Nortran subsequently, became Cardiome Pharma Corp., a successful Vancouver BC based pharmaceutical company.
CRME: 8.53 (+0.40), TLM: 7.99 (unch)
